Jim Simons Kiniksa Pharmaceuticals, Ltd. Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$10.44 - $16.48 $560,972 - $885,519	-53,733 Reduced 38.89%	84,447 $1.19 Million
Q1 2023 May 12, 2023	BUY	$10.7 - $15.79 $764,836 - $1.13 Million	71,480 Added 107.17%	138,180 $1.49 Million
Q4 2022 Feb 13, 2023	SELL	$11.42 - $17.05 $629,242 - $939,455	-55,100 Reduced 45.24%	66,700 $999,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $661,728 - $909,198	67,800 Added 125.56%	121,800 $1.56 Million
Q2 2022 Aug 12, 2022	SELL	$7.6 - $11.41 $795,720 - $1.19 Million	-104,700 Reduced 65.97%	54,000 $523,000
Q1 2022 May 13, 2022	SELL	$9.3 - $12.37 $1.34 Million - $1.79 Million	-144,600 Reduced 47.68%	158,700 $1.58 Million
Q4 2021 Feb 11, 2022	BUY	$10.39 - $15.15 $3.15 Million - $4.59 Million	303,300 New	303,300 $3.57 Million
Q1 2021 May 13, 2021	SELL	$16.68 - $23.97 $278,556 - $400,299	-16,700 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$14.8 - $21.15 $14,800 - $21,150	1,000 Added 6.37%	16,700 $295,000
Q3 2020 Nov 13, 2020	BUY	$15.21 - $25.53 $238,797 - $400,821	15,700 New	15,700 $241,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.